- Home
- INSG vs RAPT Comparison
INSG vs RAPT Comparison
Compare INSG & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSG
- RAPT
- Stock Information
- Founded
- INSG 1996
- RAPT 2015
- Country
- INSG United States
- RAPT United States
- Employees
- INSG N/A
- RAPT N/A
- Industry
- INSG Telecommunications Equipment
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- INSG Telecommunications
- RAPT Health Care
- Exchange
- INSG Nasdaq
- RAPT Nasdaq
- Market Cap
- INSG 111.5M
- RAPT 117.5M
- IPO Year
- INSG 2000
- RAPT 2019
- Fundamental
- Price
- INSG $8.48
- RAPT $0.80
- Analyst Decision
- INSG Buy
- RAPT Hold
- Analyst Count
- INSG 3
- RAPT 7
- Target Price
- INSG $13.00
- RAPT $5.00
- AVG Volume (30 Days)
- INSG 87.2K
- RAPT 826.1K
- Earning Date
- INSG 05-08-2025
- RAPT 05-08-2025
- Dividend Yield
- INSG N/A
- RAPT N/A
- EPS Growth
- INSG N/A
- RAPT N/A
- EPS
- INSG 0.10
- RAPT N/A
- Revenue
- INSG $191,244,000.00
- RAPT N/A
- Revenue This Year
- INSG $2.53
- RAPT N/A
- Revenue Next Year
- INSG $11.55
- RAPT N/A
- P/E Ratio
- INSG $81.58
- RAPT N/A
- Revenue Growth
- INSG 14.32
- RAPT N/A
- 52 Week Low
- INSG $3.70
- RAPT $0.75
- 52 Week High
- INSG $20.67
- RAPT $8.58
- Technical
- Relative Strength Index (RSI)
- INSG 53.95
- RAPT 36.83
- Support Level
- INSG $8.00
- RAPT $0.75
- Resistance Level
- INSG $8.60
- RAPT $1.01
- Average True Range (ATR)
- INSG 0.44
- RAPT 0.08
- MACD
- INSG 0.13
- RAPT 0.00
- Stochastic Oscillator
- INSG 81.16
- RAPT 18.92
About INSG Inseego Corp.
Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.